EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Deep Brain Stimulation in Children and Adolescents with ε‐Sarcoglycan Myoclonus Dystonia Causes a Sustained Improvement in Motor Functionality and Quality of Life

Ainara Salazar-Villacorta iD, Ana Cazurro-Gutiérrez iD, Lucy Dougherty-de Miguel iD, Julia Ferrero-Turrión iD, Anna Marcé-Grau iD, Marta Folch-Benito, Álvaro Lucero-Garófano iD, Alfons Macaya iD, Antonio Moreno-Galdó iD, Maria I Vanegas iD, Marta Correa-Vela iD, María Victoria González iD und 12 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.30309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Ainara Salazar-Villacorta und 23 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitari Vall d'Hebrón, Barcelona, Spain. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Quality of Life, Dystonic Disorders, Sarcoglycans. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Agència de Gestió d'Ajuts Universitaris i de Recerca, 'la Caixa' Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Deep brain stimulation of the globus pallidus internus (DBS‐GPi) has shown efficacy in adult patients with SGCE ‐related myoclonus dystonia. However, evidence regarding its impact in pediatric populations is limited.

Objectives

The aim was to evaluate motor and non‐motor outcomes following DBS‐GPi intervention in children and adolescents with SGCE ‐MD.

Methods

Ten patients (mean age 12.8 ± 3.4 years) underwent DBS‐GPi. Blinded experts rated patients with the Unified Myoclonus, Burke‐Fahn‐Marsden, Writer's cramp and Gait Dystonia rating scales. Psychiatric and quality‐of‐life outcomes were evaluated using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria and Quality of Life in Neurological Disorders.

Results

Significant improvements were observed in myoclonus (68.1%), generalized dystonia (63.2%), and dystonia during writing (48.1%), walking (70.3%) and running (44.2%) after 3.8 ± 2.4 years of the surgery. Psychiatric symptoms remained stable, while quality‐of‐life assessments revealed reductions in anxiety, fatigue, and stigma ( P < 0.05).

Conclusions

DBS‐GPi in children with SGCE ‐myoclonus dystonia mitigates long‐term disability, potentially enhancing academic, social, and professional prospects. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationQuality of LifeDystonic DisordersSarcoglycansHumansMaleChildFemaleAdolescentGlobus PallidusTreatment Outcome

Substanzen

Sarcoglycans

Autor:innen und Institutionen

  • Hospital Universitari Vall d'Hebrón, Barcelona, Spain.
  • University College London, Institute of Neurology, London, United Kingdom.
  • Institut Recerca Vall d'Hebrón, Barcelona, Spain.
  • Departments of Pediatrics and Psychiatry, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • European Reference Network for Rare Neurological Diseases (ERN-RND), Barcelona, Spain.
  • Biomedical Research Networking Center on Rare Diseases (CIBERER), Group CB6/07/0063.

ORCID-Profile: Ainara Salazar-Villacorta, Ana Cazurro-Gutiérrez, Lucy Dougherty-de Miguel, Julia Ferrero-Turrión, Anna Marcé-Grau, Álvaro Lucero-Garófano, Alfons Macaya, Antonio Moreno-Galdó, Maria I Vanegas, Marta Correa-Vela, María Victoria González, Gemma Español-Martín, Ignacio Delgado, Esther Toro-Tamargo, Dolores Vilas, Ramiro Álvarez, Agustí Bescós, Belén Pérez-Dueñas

Förderung

  • Instituto de Salud Carlos III
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • 'la Caixa' Foundation
  • Boston Scientific Corporation

Zitieren

APA

Salazar-Villacorta, A., Cazurro-Gutiérrez, A., Dougherty-de Miguel, L., Ferrero-Turrión, J., Marcé-Grau, A., Folch-Benito, M., Lucero-Garófano, Á., Macaya, A., Moreno-Galdó, A., Vanegas, M. I., Correa-Vela, M., González, M. V., Español-Martín, G., Loredo, M., Delgado, I., Toro-Tamargo, E., Figueroa, M., Vilas, D., Tardáguila, M., …, & Pérez-Dueñas, B. (2025). Deep Brain Stimulation in Children and Adolescents with ε‐Sarcoglycan Myoclonus Dystonia Causes a Sustained Improvement in Motor Functionality and Quality of Life. Movement Disorders. https://doi.org/10.1002/mds.30309

Vancouver

Salazar-Villacorta A, Cazurro-Gutiérrez A, Dougherty-de Miguel L, Ferrero-Turrión J, Marcé-Grau A, Folch-Benito M, et al. Deep Brain Stimulation in Children and Adolescents with ε‐Sarcoglycan Myoclonus Dystonia Causes a Sustained Improvement in Motor Functionality and Quality of Life. Movement Disorders. 2025. doi:10.1002/mds.30309

BibTeX
@article{SalazarVillacorta2025,
  author = {Salazar-Villacorta, Ainara and Cazurro-Gutiérrez, Ana and Dougherty-de Miguel, Lucy and Ferrero-Turrión, Julia and Marcé-Grau, Anna and Folch-Benito, Marta and Lucero-Garófano, Álvaro and Macaya, Alfons and Moreno-Galdó, Antonio and Vanegas, Maria I and Correa-Vela, Marta and González, María Victoria and Español-Martín, Gemma and Loredo, Martha and Delgado, Ignacio and Toro-Tamargo, Esther and Figueroa, Margarita and Vilas, Dolores and Tardáguila, Manel and Muñoz, Jorge and Ispierto, Lourdes and Álvarez, Ramiro and Bescós, Agustí and Pérez-Dueñas, Belén},
  title = {Deep Brain Stimulation in Children and Adolescents with ε‐Sarcoglycan Myoclonus Dystonia Causes a Sustained Improvement in Motor Functionality and Quality of Life},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30309}
}
Kostenlos starten →